Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01180777 · ClinicalTrials.gov registry record · NA
Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT01180777 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants.
The verdict
NCT01180777, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the lens fit (mechanical and cosmetic lens fit) of the printed etafilcon A with polyvinylpyrrolidone (PVP).
Interventions
- DEVICE etafilcon A (A)
- DEVICE etafilcon A (B)
- DEVICE etafilcon A (C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2010-07-01 |
| Est. Completion | 2010-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01180777
The ClinicalTrials.gov registry entry for NCT01180777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which etafilcon A (A) is the first listed.
NCT01180777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01180777 about?
NCT01180777 is a clinical study titled "Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)". The purpose of this study is to evaluate the lens fit (mechanical and cosmetic lens fit) of the printed etafilcon A with polyvinylpyrrolidone (PVP).
What is the current status of trial NCT01180777?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2010-07-01. Estimated completion is 2010-08-01.
What interventions are being tested in trial NCT01180777?
The interventions under investigation include: etafilcon A (A) (DEVICE), etafilcon A (B) (DEVICE), etafilcon A (C) (DEVICE).
Who is sponsoring clinical trial NCT01180777?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.